BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 8.57 | -0.99 | 13.66 | 17.06 | 16.49 |
What is the latest Profit After Tax (PAT) Margin ratio of BALAXI PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 8.57 |
| Mar2024 | -0.99 |
| Mar2023 | 13.66 |
| Mar2022 | 17.06 |
| Mar2021 | 16.49 |
How is Profit After Tax (PAT) Margin of BALAXI PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 8.57 | Positive | |
| Mar2024 | -0.99 | Negative | |
| Mar2023 | 13.66 | -19.93 | |
| Mar2022 | 17.06 | 3.46 | |
| Mar2021 | 16.49 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹180.3 Cr | -8.1% | -21.9% | -58.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹286,394.0 Cr | -1.1% | -3.6% | -6.4% | Stock Analytics | |
| REDINGTON | ₹20,967.2 Cr | -4.3% | -8.1% | 30.1% | Stock Analytics | |
| HONASA CONSUMER | ₹8,344.1 Cr | -10.3% | -6.3% | -1.3% | Stock Analytics | |
| MMTC | ₹8,172.0 Cr | -8.1% | -16.6% | -29.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,970.1 Cr | -6.5% | -21.3% | 19.5% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -8.1% |
-21.9% |
-58.8% |
| SENSEX | -0.6% |
2.2% |
5.3% |
You may also like the below Video Courses